Imatinib and beyond - the new CML study IV: A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia - Berger, Ute; Engelich, G.; Reiter, Andreas; Hochhaus, Andreas; Hehlmann, Rüdiger (Annals of hematology, 2004)
Published: 29 November 2003
Gesehen am 12.05.2022